Steven Cohen’s Solid Biosciences SLDB Stock Holding History

Steven Cohen’s Portfolio SLDB Stock Details SLDB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.48M	Sell	448,008 -1,602,835	-78%	-$12.2M	﹤0.01%	1834
2026 Q1	$14.8M	Sell	2,050,843 -365,265	-15%	-$2.35M	0.02%	989
2025 Q4	$13.6M	Buy	2,416,108 +1,083,103	+81%	+$5.87M	0.02%	1152
2025 Q3	$8.22M	Buy	1,333,005 +66,948	+5%	+$391K	0.01%	879
2025 Q2	$6.17M	Buy	1,266,057 +1,064,638	+529%	+$3.76M	0.01%	899
2025 Q1	$745K	Buy	+201,419	New	+$862K	﹤0.01%	1526
2024 Q4	–	Sell	-443,010	Closed	-$3.09M	–	2421
2024 Q3	$3.09M	Buy	443,010 +330,234	+293%	+$2.68M	0.01%	1031
2024 Q2	$639K	Buy	+112,776	New	+$1.01M	﹤0.01%	1381

Other funds holding SLDB

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Steven Cohen's SLDB Position: Q2 2026 in Review

Steven Cohen reduced its Solid Biosciences (SLDB) stake by 78% in Q2 2026, selling an estimated $12.2M and leaving 448,008 shares worth $4.48M. The position accounts for ﹤0.01% of the portfolio, ranked #1834.

Steven Cohen first reported a position in SLDB in Q2 2024 and has held it in 8 quarters since. The position peaked at $14.8M in Q1 2026. 155 funds tracked by Wall St. Rank hold SLDB as of Q2 2026.

Steven Cohen held 448,008 shares of Solid Biosciences worth $4.48M as of Q2 2026.
Steven Cohen sold 1,602,835 Solid Biosciences shares in Q2 2026, an estimated $12.2M.
Solid Biosciences made up ﹤0.01% of Steven Cohen's portfolio in Q2 2026, its #1834 holding.
Steven Cohen first reported a position in Solid Biosciences in Q2 2024 and has held it in 8 quarters since.
Steven Cohen's Solid Biosciences position peaked at $14.8M in Q1 2026.
155 funds tracked by Wall St. Rank held Solid Biosciences as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.